| Dr Sleiman Khalil Smaili, MD | |
|
3125 Transverse Dr, Toledo, OH 43614-8008 | |
| (419) 383-3787 | |
| (419) 383-6046 |
| Full Name | Dr Sleiman Khalil Smaili |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 3125 Transverse Dr, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477718245 | NPI | - | NPPES |
| 3080473 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35096040 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Toledo Medical Center | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Toledo Physicians Llc | 8729983416 | 315 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
A device that performs ultrafiltration of blood, without requiring specialized nursing care or invasive central intravenous access, can reduce fluid overload in patients with congestive heart failure, according to a new study in the Dec. 6, 2005, issue of the Journal of the American College of Cardiology.
Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. The rare genetic variant offers important insights into the root causes of autism, the researchers say. And, they suggest, their unconventional method can be used to identify other genetic causes of autism and other complex genetic conditions.
› Verified 9 days ago
| Entity Name | University Of Toledo Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942296033 PECOS PAC ID: 8729983416 Enrollment ID: O20031205000019 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
A device that performs ultrafiltration of blood, without requiring specialized nursing care or invasive central intravenous access, can reduce fluid overload in patients with congestive heart failure, according to a new study in the Dec. 6, 2005, issue of the Journal of the American College of Cardiology.
Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. The rare genetic variant offers important insights into the root causes of autism, the researchers say. And, they suggest, their unconventional method can be used to identify other genetic causes of autism and other complex genetic conditions.
› Verified 9 days ago
| Entity Name | The Toledo Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407854771 PECOS PAC ID: 2961309638 Enrollment ID: O20031218001042 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
A device that performs ultrafiltration of blood, without requiring specialized nursing care or invasive central intravenous access, can reduce fluid overload in patients with congestive heart failure, according to a new study in the Dec. 6, 2005, issue of the Journal of the American College of Cardiology.
Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. The rare genetic variant offers important insights into the root causes of autism, the researchers say. And, they suggest, their unconventional method can be used to identify other genetic causes of autism and other complex genetic conditions.
› Verified 9 days ago
| Entity Name | Bay Park Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598765539 PECOS PAC ID: 1951200872 Enrollment ID: O20040108000599 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
A device that performs ultrafiltration of blood, without requiring specialized nursing care or invasive central intravenous access, can reduce fluid overload in patients with congestive heart failure, according to a new study in the Dec. 6, 2005, issue of the Journal of the American College of Cardiology.
Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. The rare genetic variant offers important insights into the root causes of autism, the researchers say. And, they suggest, their unconventional method can be used to identify other genetic causes of autism and other complex genetic conditions.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sleiman Khalil Smaili, MD 3355 Glendale Ave Fl 3, Toledo, OH 43614-2426 Ph: (419) 383-3787 | Dr Sleiman Khalil Smaili, MD 3125 Transverse Dr, Toledo, OH 43614-8008 Ph: (419) 383-3787 |
News Archive
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
A device that performs ultrafiltration of blood, without requiring specialized nursing care or invasive central intravenous access, can reduce fluid overload in patients with congestive heart failure, according to a new study in the Dec. 6, 2005, issue of the Journal of the American College of Cardiology.
Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. The rare genetic variant offers important insights into the root causes of autism, the researchers say. And, they suggest, their unconventional method can be used to identify other genetic causes of autism and other complex genetic conditions.
› Verified 9 days ago
Nadine C Kassis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3425 Executive Pkwy, Suite 108, Toledo, OH 43606 Phone: 419-214-3192 | |
Anthony J. Armstrong, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4126 N Holland Sylvania Rd, Suite 220, Toledo, OH 43623 Phone: 419-517-7600 Fax: 419-517-7598 | |
Luigi O D'amato, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3740 W Sylvania Ave, Suite 103, Toledo, OH 43623 Phone: 419-473-6622 Fax: 419-473-6627 | |
Lance A Talmage, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2200 Fax: 419-479-3297 | |
Dr. Sonyoung Seo-patel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2192 Fax: 419-479-3297 | |
Dr. Kathryn Shannon Maloy, M.D., MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2213 Cherry St, Toledo, OH 43608 Phone: 419-251-3232 Fax: 419-251-3997 | |
Tiberiu S. Avram, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3020 N Mccord Rd Ste 201a, Toledo, OH 43615 Phone: 419-517-7727 Fax: 419-517-5036 |